awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33588346-0F8786B3-4999-414A-A123-07E652B16B29
Q33588346-0F8786B3-4999-414A-A123-07E652B16B29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588346-0F8786B3-4999-414A-A123-07E652B16B29
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain
P2860
Q33588346-0F8786B3-4999-414A-A123-07E652B16B29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588346-0F8786B3-4999-414A-A123-07E652B16B29
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5eb72ba7d0d6fa1c44c64be34ef7bd9c6354b140
P2860
Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.